ARCHIVES

Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction”

This article is from The Cancer Letter archive.

Vol. 24 No. 34 | September 11, 1998

Download PDF Visit The Full Archive

Related Articles

Cancer Informatics: NCI Writing Dictionary To Standardize Data Reported In Trials

November 13, 1998

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

February 24, 2006

In Brief: Administration “Streamlining” Accomplished; DCCR contract Merit Review In Open Session

February 24, 1978

Congress Passes FDA User Fee Bill, Averting Layoffs.

September 21, 2007

In Brief: Murphy Choice Of Ohio State Search Committee To Head Cancer Hospital; Decision Due In Oct.

September 19, 1986

Cancer Policy: New Cancer Board to Take A Year to Conduct First Study

April 18, 1997